SCHEMBL19804072

SCHEMBL19804072

C=C(C)C(=O)OCCOc1cc(C2CCC(C3CCCCC3)CC2)ccc1OCCO

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 4/20 0.40
TSHR P16473 1/20 0.38
RAB9A P51151 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
KMT2A Q03164 1/20 0.37
PDE4A P27815 4/20 0.37
PDE4B Q07343 4/20 0.37
PDE4C Q08493 4/20 0.37
PDE4D Q08499 4/20 0.37
MCHR1 Q99705 3/20 0.36
PPARG P37231 3/20 0.35
PPARA Q07869 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CACNA1F O60840 2/20 0.35
CACNA1D Q01668 2/20 0.35
CACNA1S Q13698 2/20 0.35
CACNA1C Q13936 2/20 0.35
HRH3 Q9Y5N1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19624509 0.91 CSF1R (0.38) CSF1RTSHRRAB9AKDM4EALDH1A1
SCHEMBL19804491 0.90 PPARG (0.37) CSF1RTSHRRAB9APDE4APDE4B
SCHEMBL19804401 0.89 CYP3A4 (0.41) CSF1RTSHRRAB9AKDM4EALDH1A1
SCHEMBL19804434 0.89 PDE4A (0.35) CSF1RPDE4APDE4BPDE4CPDE4D
SCHEMBL19804134 0.89 CSF1R (0.40) CSF1RTSHRRAB9AKDM4EALDH1A1
SCHEMBL19804400 0.88 PPARG (0.38) CSF1RTSHRRAB9APDE4APDE4B
SCHEMBL19804245 0.88 HPGD (0.36) CSF1RPDE4APDE4BPDE4CPDE4D
SCHEMBL19804356 0.87 CA1 (0.36) CSF1RPDE4APDE4BPDE4CPDE4D
SCHEMBL19804501 0.87 PPARG (0.37) CSF1RTSHRRAB9APDE4APDE4B
SCHEMBL19804436 0.87 CSF1R (0.37) CSF1RTSHRRAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 CSF1R 3027/4885TSHR 4195/4885RAB9A 4200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.